Please assess the completion status of the following clinical trial:

Trial Title: Anti-Tumor Necrosis Factor (TNF) Treatments, Work Productivity and Quality of Life in Crohn's Disease

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Male or female participants between 18-65 years of age with moderately to severely (Crohn's Disease Activity Index 220-450) active Crohn's Disease with or without fistula formation~* Participants who were able to provide authorization to use and disclose information related to the study~* Proven diagnosis of Crohn's Disease in accordance with international diagnostic criteria such as European Crohn's and Colitis Organization (ECCO) guidelines~* Participants for whom the physician had initiated anti-Tumor Necrosis Factor treatment in accordance with Turkish Ministry of Health regulations and reimbursements~Exclusion Criteria:~* Participants who had a history of any kind of biological therapy and/or anti-Tumor Necrosis Factor treatments for Crohn's Disease or other indications~* Participants who had septic complications (active infection and/or active tuberculosis (TB), undrained abscess)~* Participants who had bowel obstructions and fibrotic strictures~* Participants who had received any investigational drug within 30 days prior to the Visit 1 at baseline~* For any reason, participants who were considered by the investigator to be unsuitable

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Participants with moderate to severe Crohn's Disease (Type: None): Participants for whom the treating physician had recently initiated an anti-Tumor Necrosis Factor (TNF) treatment

Based on this trial design, predict the completion outcome and termination type (if applicable).